NCT00416624
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +72 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Mastocytosis, Systemic
Explore clinical trials studying Mastocytosis, Systemic. Study availability and eligibility vary by location and protocol.
33 public trials
2 recruiting studies
Mastocytosis, Systemic trial results
NCT00719563
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
Completed
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
NCT00154388
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
- Locations
-
Not specified
NCT00890435
- Conditions
- Astrocytoma, Bone Marrow Diseases, Brain Diseases, +67 more
- Locations
-
Not specified
NCT00996047
- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
- Locations
-
- Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
- Providence Cancer Center Anchorage, Alaska, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
NCT01231919
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Childrens Hospital of Orange County Orange, California, United States
- University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
NCT00627666
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +38 more
- Locations
-
- Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea
NCT00823524
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- University of Ulsan, Asan Medical Center Seoul, South Korea
NCT00666211
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
- Locations
-
- Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
- Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
- Erlanger Health System Chattanooga, Tennessee, United States
- Tennessee Plateau Oncology Crossville, Tennessee, United States